Merilee Raines's most recent trade in Ocular Therapeutix Inc was a trade of 44,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 14,000 | 46,933 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 2,134 | 4,059 (0%) | 0% | 0 | Common Stock | |
| Watts Water Technologies, ... | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2024 | 678 | 20,698 (0%) | 0% | 0 | Class A Common Stock | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2024 | 12,000 | 32,933 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,154 | 1,154 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 732 | 1,925 (0%) | 0% | 0 | Common Stock | |
| Watts Water Technologies, ... | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jul 2023 | 713 | 20,020 (0%) | 0% | 0 | Class A Common Stock | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,000 | 20,933 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,916 | 1,916 | - | - | Stock Option (Right to Buy) | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,193 | 1,193 (0%) | 0% | 0 | Common Stock | |
| Watts Water Technologies, ... | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 1,019 | 19,307 (0%) | 0% | 0 | Class A Common Stock | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,800 | 26,800 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 8,933 | 8,933 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,500 | 13,500 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 36,000 | 36,000 | - | - | Stock Option (Right to Buy) | |
| Watts Water Technologies, ... | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 794 | 18,288 (0%) | 0% | 0 | Class A Common Stock | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 2,250 | 2,250 | - | - | Stock Option (Right to Buy) | |
| Benchmark Electronics Inc. | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 5,200 | 24,489 (0%) | 0% | 0 | Common Stock | |
| Transmedics Group Inc | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Watts Water Technologies, ... | Merilee Raines | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,359 | 17,494 (0%) | 0% | 0 | Class A Common Stock |